Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 October 2006, Vol. 108, No. 8, pp. 2554-2561.
Prepublished online as a Blood First Edition Paper on June 20, 2006; DOI 10.1182/blood-2006-04-008532.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-04-008532v1
108/8/2554    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, A. L
Right arrow Articles by Baker, A. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, A. L
Right arrow Articles by Baker, A. H
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted April 14, 2006
Accepted June 7, 2006

Multiple Vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes in vitro and in vivo

Alan L Parker, Simon N Waddington, Campbell Nicol, Dmitry M Shayakhmetov, Suzanne M Buckley, Laura Denby, Geoffrey Kemball-Cook, Shaoheng Ni, Andre Lieber, John H McVey, Stuart A Nicklin, and Andrew H Baker*

British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, UK
Imperial College London, Gene Therapy Research Group, Sir Alexander Fleming Building, London, UK
Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA, USA
Imperial College London, Haemostasis and Thrombosis, MRC Clinical Sciences Centre, London, UK

* Corresponding author; email: ab11f{at}clinmed.gla.ac.uk.

Upon local delivery adenovirus serotype 5 viruses use the coxsackie and adenovirus receptor (CAR) for cell binding and {alpha}{nu} integrins for internalisation. When administered systemically, however, their role in liver tropism is limited since CAR-permissive and mutated viruses show similar biodistribution, a finding recently attributed to blood coagulation Factor (F) IX or complement protein C4BP binding to the adenovirus fiber and " bridging" to either low-density lipoprotein receptor-related protein or heparan sulphate proteoglycans. Here, we show that hepatocyte transduction in vitro can be enhanced by the vitamin K-dependent factors FX, protein C and FVII in addition to FIX, but not by prothrombin (FII), FXI and FXII. This phenomenon was not dependent on proteolytic activation or cell signalling activity and for FX was mediated by direct virus:factor binding. Human FX substantially enhanced hepatocyte transduction by CAR-permissive and mutated viruses in an ex vivo liver perfusion model. In vivo, global downregulation of vitamin K-dependent zymogens by warfarin significantly diminished liver uptake of CAR-deleted adenoviruses, however this phenomenon was fully rescued by acute infusion of human FX. Our results indicate a common and pivotal role for distinct vitamin K-dependent coagulation factors in mediating hepatocyte transduction by adenoviruses in vitro and in vivo.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020